EMEA-002906-PIP01-20
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0085/2021
|
| PIP number |
EMEA-002906-PIP01-20
|
| Pharmaceutical form(s) |
Capsule, hard
|
| Condition(s) / indication(s) |
Treatment of hypertension
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Sandoz GmbH
E-mail: caroline.kleinjan@sandoz.com
Tel: +31 365241710 |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|